Abeo down 12% on gene therapy data in Sanfilippo – Seeking Alpha
Reurope |
Abeo down 12% on gene therapy data in Sanfilippo
Seeking Alpha Abeona Therapeutics (ABEO -11.5%) is down on a 50% spike in volume following its release of updated data from a Phase 1/2 clinical trial assessing gene therapy ABO-102 in patients with Sanfilippo syndrome type A (MPS III A), a rare inherited disorder … Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT Meeting Abeona Reports Update from EB-101 Gene Therapy in Epidermolysis Bullosa at 21st Annual ASGCT Meeting Abeona Therapeutics (ABEO) Announces Clinical Update on MPS IIIA Gene Therapy Trial |
